Specialized news

Summary of 5 hereditary cancer testing packages at Eurofins GENTIS

Cancer is one of the leading causes of death worldwide. Numerous studies indicate that 5–10% of cancer cases are associated with hereditary factors, resulting from gene mutations that can be passed down from one generation to the next. Hereditary cancer testing helps identify risks early, enabling the development of appropriate monitoring, prevention, and medical intervention strategies.

Eurofins GENTIS and Phenikaa hospital strengthen professional exchange on preimplantation genetic testing

In recent years, alongside in vitro fertilization (IVF), preimplantation genetic testing (PGT) solutions have increasingly been recognized as a key factor in improving success rates, minimizing risks, and working toward the goal of delivering healthy babies. Scientifically guided embryo selection plays a crucial role in helping clinicians and patients make safer and more effective decisions in each treatment cycle.

Trends and applications of AI and omics data in genetic testing and reproductive genetic counseling

In recent years, artificial intelligence (AI) has emerged as one of the key driving forces behind the technological revolution across many fields, especially healthcare. From medical imaging diagnostics and chronic disease management to drug research and development, AI has demonstrated its pivotal role in improving treatment effectiveness and personalizing healthcare. In the field of genetics and assisted reproduction, the integration of AI, bioinformatics, and Omics data is expected to create major breakthroughs, significantly enhancing the quality of screening, diagnosis, and genetic counseling.

Congratulations on the successful December prenatal class – The journey to happy motherhood of Andrology and Fertility hospital of Hanoi

On the morning of December 27, 2025, at the 5th Floor Hall – Building A, Andrology and Fertility hospital of Hanoi, the program “Prenatal Class – The Journey to Happy Motherhood” was successfully held, leaving many deep emotions and meaningful values for all expectant mothers and their families in attendance. The program was not only a simple medical knowledge-sharing session but also a journey of spreading love, understanding, and strong faith for families preparing to welcome their little angels.

Eurofins GENTIS & andrology and fertility hospital of Hanoi announce research on recurrent pregnancy loss: The role of multigene sequencing in genetic screening and counseling

Recently, the scientific study entitled “Recurrent Pregnancy Loss: The Role of Multigene Sequencing in Genetic Screening and Counseling,” conducted by Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility, was officially published in Issue No. 197 of the Journal of Medical Research.

Eurofins GENTIS & Andrology and fertility hospital of Hanoi publish research findings on recurrent pregnancy loss in the journal of medical research

Recently, Eurofins GENTIS and the Hanoi Hospital of Andrology and Infertility officially published the results of their scientific study evaluating the role of multigene sequencing (NGS) — specifically the FertiScan™ panel — in identifying genetic causes in women with a history of recurrent pregnancy loss (RPL).

Eurofins GENTIS pioneers the deployment of Next-Generation sequencing technology MiSeq i100 Plus in Vietnam

Eurofins GENTIS has officially marked a major milestone by becoming the first organization in Vietnam to install and deploy the MiSeq i100 Plus system — the latest next-generation sequencing (NGS) technology from Illumina. This achievement strongly affirms Eurofins GENTIS’s long-term commitment to continuously advancing genetic diagnostic capabilities and aligning with the highest standards of modern global medicine.

Preimplantation genetic testing: A key to improving IVF success and protecting future generations

In recent years, in vitro fertilization (IVF) has become a vital solution helping tens of thousands of Vietnamese couples realize their dream of parenthood.